Clonal hematopoiesis is not significantly associated with COVID-19 disease severity
Open Access
- 19 July 2022
- journal article
- letter
- Published by American Society of Hematology in Blood
- Vol. 140 (14) , 1650-1655
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal HematopoiesisCirculation, 2020
- Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesisBlood Advances, 2019
- Clonal HematopoiesisJACC, 2019
- Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient hostNature, 2018
- Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 InflammasomeJACC, 2018
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6Nature, 2015
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceNew England Journal of Medicine, 2014
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- Subclonal variant calling with multiple samples and prior knowledgeBioinformatics, 2014